Transient raise of endothelin-1 plasma level and reduction of ocular blood flow in a patient with optic neuritis

Ophthalmologica

Volumn 217, Issue 6, 2003, Pages 451-453

  Haufschild, Timo ^a   Shaw, Sidney G ^b   Kaiser, Hedwig J ^a   Flammer, Josef ^a  

^a UNIVERSITY EYE CLINIC   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Endothelin 1; Multiple sclerosis; Optic neuritis; Vascular dysregulation

Indexed keywords

ENDOTHELIN 1; METHYLPREDNISOLONE; PREDNISONE;

ACUTE PHASE RESPONSE; ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; DISEASE COURSE; EYE BLOOD FLOW; HUMAN; ISCHEMIC OPTIC NEUROPATHY; LABORATORY TEST; MALE; MEDICAL EXAMINATION; OCULAR BLOOD VESSEL; OPTIC NERVE; PROTEIN BLOOD LEVEL; SEROLOGY; SYSTEMIC DISEASE; TREATMENT OUTCOME;

ADULT; BLOOD FLOW VELOCITY; ENDOTHELIN-1; HUMANS; MALE; OPTIC NEURITIS; REGIONAL BLOOD FLOW; RETINAL ARTERY; VISUAL ACUITY; VISUAL FIELDS;

EID: 0142196698     PISSN: 00303755     EISSN: None     Source Type: Journal    
DOI: 10.1159/000073079     Document Type: Article

References (6)

1. Barton M, Shaw SG, d'Uscio L et al: Angiotensin increases vascular and retinal endothelin-1 and functional endothelin-converting enzyme activity in vivo: Role of ETA receptors for endothelin regulation. Biochem Biophys Res Commun 1997;238:861-865.
2. Schmetterer L, Findl O, Strenn K et al: Effects of endothelin-1 on ocular hemodynamics. Curr Eye Res 1997;16:687-692.
3. Strenn K, Matulla B, Wolzt M et al: Reversal of endothelin-1-induced ocular hemodynamic effects by low-dose nifedipine in humans. Clin Pharmacol Ther 1998;63:54-63.
4. Flammer J, Pache M, Resink T: Vasospasm, its role in the pathogenesis of diseases with particular reference to the eye. Prog Ret Eye Res 2001;20:319-349.
5. Haufschild T, Shaw SG, Kesselring J, Flammer J: Increased endothelin-1 plasma levels in patients with multiple sclerosis. J Neuroophthal-mol 2001;21:37-38.
6. Speciale L, Sarasella M, Ruzzante S et al: Endo-thelin and nitric oxide levels in cerebrospinal fluid of patients with multiple sclerosis. J Neu-rovirol 2000;6(suppl):62-66.